Gold extended rally from $4850 zone higher base into fourth consecutive day and hit the highest since Jan 30 in early trading on Monday. Fresh wave of safe-haven demand was boosted by the latest decision Read more…
Daily Pivots: (S1) 1.1747; (P) 1.1778; (R1) 1.1811; More…. EUR/USD retreated mildly after hitting 55 4H EMA but stays above 1.1740 temporary low. Intraday bias stays neutral for the moment. Near term risk will remain Read more…
Dollar stabilized and recovered notably in early US trading after an initial selloff, supported by remarks from Fed Governor Christopher Waller. Waller, widely regarded as one of the more dovish voices on the Federal Reserve Read more…
Tempest 3.0 has been released with a new exception handler, PHP 8.5 as minimum requirement, improved CSRF protection using browser headers, database performance improvements, and closure-based validation rules. Read more
For more than two decades, Amazon has been at the center of the online shopping evolution, making it possible for consumers to purchase nearly any product and receive it at their doorstep within days or Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Some days, it feels like everything Read more…
Fed Governor Christopher Waller said in a speech that recent economic data, particularly January’s employment report, came in “substantially stronger” than expected, suggesting labor market risks may have “diminished”. He noted that the initial estimate Read more…
When I first saw Elon Musk write that he would “probably end up paying over $500B in taxes, inclusive of death,” I had to read it twice just to make sure he hadn’t added an Read more…
Alan Taylor reinforced his dovish stance in remarks at a Deutsche Bank event in London today, arguing that inflation risks are shifting away from stickiness and toward undershooting the 2% target. He suggested weakening demand Read more…
Broadcast Retirement Network’s Jeffrey Snyder discusses the use of Artificial Intelligence in the creation of new drug with Early-Stage Biotech Scientist Andrew R. Snyder, PhD. Jeffrey Snyder, Broadcast Retirement Network Joining me now is Dr. Read more…